Susceptibility-weighted imaging improves the diagnostic accuracy of 3T brain MRI in the work-up of Parkinsonism

American Journal of Neuroradiology

Volumn 36, Issue 3, 2015, Pages 454-460

  Meijer, Frederick J A ^a   Van Rumund, A ^a   Fasen, B A C M ^a   Titulaer, I ^a   Aerts, M ^a   Esselink, R ^a   Bloem, B R ^a   Verbeek, M M ^a   Goraj, B ^a,b  

^a RADBOUD UNIVERSITY   (Netherlands)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATYPICAL PARKINSONISM; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OBSERVATIONAL STUDY; PARKINSON DISEASE; PARKINSONISM; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SHY DRAGER SYNDROME; SUSCEPTIBILITY WEIGHTED IMAGING; UNIFIED PARKINSON DISEASE RATING SCALE; ANALYSIS OF VARIANCE; COMPUTER ASSISTED DIAGNOSIS; PARKINSONIAN DISORDERS; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC;

AGED; ANALYSIS OF VARIANCE; COHORT STUDIES; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; PARKINSONIAN DISORDERS; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84924916146     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A4140     Document Type: Article

References (43)

1. Berardelli A, Wenning GK, Antonini A, et al. EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease. Eur J Neurol 2013;20:16-34
2. Brooks DJ. Morphological and functional imaging studies on the diagnosis and progression of Parkinson's disease. J Neurol 2000;247(suppl 2):11-18
3. Schrag A, Good CD, Miszkiel K, et al. Differentiation of atypical parkinsonian syndromes with conventional brain MRI. Neurology 2000;54:697-702
4. Mahlknecht P, Hotter A, Hussl A, et al. Significance of MRI in diagnosis and differential diagnosis of Parkinson's disease. Neurodegener Dis 2010;7:300-18
5. Meijer FJ, Aerts MB, Abdo WF, et al. Contribution of conventional brain MRI to the differential diagnosis of parkinsonism: a 3-year prospective follow-up study. J Neurol 2012;259:929-35
6. Haacke EM, Xu Y, Cheng YC, et al. Susceptibility weighted imaging (SWI). Magn Reson Med 2004;52:612-18
7. Haacke EM, Cheng NY, House MJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005;23:1-25
8. Sehgal V, Delproposto Z, Haacke EM, et al. Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging 2005;22:439-50
9. Berg D, Hochstrasser H. Iron metabolism in Parkinsonian syndromes. Mov Disord 2006;21:1299-310
10. Haacke EM, Ayaz M, Khan A, et al. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in brain. J Magn Reson Imaging 2007;26:256-64
11. Harder SL, Hopp KM, Ward H, et al. Mineralization of the deep gray matter with age: a retrospective review with susceptibilityweighted MR imaging. AJNR Am J Neuroradiol 2008;29:176-83
12. Friedman A, Galazka-Friedman J, Koziorowski D. Iron as a cause of Parkinson disease: a myth or a well-established hypothesis? Parkinsonism Relat Disord 2009;15(suppl 3):212-14
13. Gupta D, Saini J, Kesavadas C, et al. Utility of susceptibilityweighted MRI in differentiating Parkinson's disease and atypical parkinsonian syndromes. Neuroradiology 2010;52:1087-94
14. Wang Y, Butros SC, Shuai X, et al. Different iron-deposition patterns of multiple system atrophy with predominant parkinsonism and idiopathetic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging. AJNR Am J Neuroradiol 2012;33:266-73
15. Chaudhuri KR, Martinez-Martin P. Quantitation of non-motor symptoms in Parkinson's disease. Eur J Neurol 2008;15(suppl 2):2-7
16. Folstein MF, Robins LN, Helzer JE. The Mini-Mental State Examination. Arch Gen Psychiatry 1983;40:812
17. Fahn S, Elton RL. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, eds. Recent Developments in Parkinson's Disease. Vol 2. Florham Park: MacMillan Healthcare Information; 1987:153-63
18. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967;17:427-42
19. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-39
20. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008;71:670-76
21. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9
22. McKeith IG, Dickson DW, Lowe J, et al. Consortium on DLB: diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863-72
23. Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 2003;54(suppl 5):15-19
24. Zijlmans JC, Daniel SE, Hughes AJ, et al. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 2004;19:630-40
25. Yekhlef F, Ballan G, Macia F, et al. Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD. J Neural Transm 2003;110:151-69
26. Lee WH, Lee CC, Shyu WC, et al. Hyperintense putaminal rim sign is not a hallmark of multiple system atrophy at 3T. AJNR Am J Neuroradiol 2005;26:2238-42
27. Hallgren B, and Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochem 1958;3:41-51
28. Martin WW, Ye FQ, Allen PS. Increasing striatal iron content associated with normal aging. Mov Disord 1998;13:281-86
29. Drayer BP, Olanow W, Burger P, et al. Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron. Radiology 1986;159:493-98
30. Martin WR, Roberts TE, Ye FQ, et al. Increased basal ganglia iron in striatonigral degeneration: in vivo estimation with magnetic resonance. Can J Neurol Sci 1998;25:44-47
31. Vymazal J, Righini A, Brooks RA, et al. T1 and T2 in the brain of healthy subjects, patients with Parkinson disease and patients with multiple system atrophy: relation to iron content. Radiology 1999;211:489-95
32. Kraft E, Schwarz J, Trenkwalder C, et al. The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy? Arch Neurol 1999;56:225-28
33. Kraft E, Trenkwalder C, Auer DP. T2∗-weighted MRI differentiates multiple system atrophy from Parkinson's disease. Neurology 2002;59:1256-67
34. Haller S, Badoud S, Nguyen D, et al. Differentiation between Parkinson disease and other forms of Parkinsonism using support vector machine analysis of susceptibility-weighted imaging (SWI): initial results. Eur Radiol 2013;23:12-19
35. Collins SJ, Ahlskog JE, Parisi JE, et al. Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry 1995;58:167-73
36. Nandigam RN, Viswanathan A, Delgado P, et al. MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength. AJNR Am J Neuroradiol 2009;30:338-43
37. Wardlaw JM, Brindle W, Casado AM, et al. Asystematic review of the utility of 1.5 versus 3 Tesla magnetic resonance brain imaging in clinical practice and research. Eur Radiol 2012;22:2295-303
38. Martin WR, Wieler M, Gee M. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 2008;70:1411-17
39. Rossi ME, Ruottinen H, Saunamäki T, et al. Imaging brain iron and diffusion patterns: a follow-up study of Parkinson's disease in the initial stages. Acad Radiol 2014;21:64-71
40. Blazejewska AI, Schwarz ST, Pitiot A, et al. Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI. Neurology 2013;81:534-40
41. Kwon DH, Kim JM, Oh SH, et al. Seven-Tesla magnetic resonance images of the substantia nigra in Parkinson disease. Ann Neurol 2012;71:267-77
42. Schwarz ST, Afzal M, Morgan PS, et al. The 'swallow tail' appearance of the healthy nigrosome: a new accurate test of Parkinson's disease - a case-control and retrospective cross-sectional MRI study at 3T. PLoS One 2014;9:e93814
43. Hughes AJ, Daniel SE, Ben Shlomo Y, et al. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002;125:861-70